NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Perelel

Perelel

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://perelelhealth.com/

Last Round

Series A

Extension

Nov 20, 2025

Est. Valuation

$145M

Total Funding Raised

$37.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Perelel is a femtech company that provides doctor-formulated vitamin supplements for women's reproductive and hormonal health.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Subscription Commerce, E-commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

prenatal vitaminspostnatal vitaminsdirect-to-consumerDTCsubscription boxfertility supplementswomen's healthnutritional supplementsfemtechconception supportvitamin subscriptionpostpartum recoverywellness supplementsdoctor-formulatedconsumer packaged goodsCPG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Perelel Comparables

Compare Perelel with similar companies based on industry and business-model similarity.

Perelel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Needed
94%
Ritual
86%
Binto
83%

Perelel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 20, 2025
Series AFeb 1, 2024
SeedJul 19, 2022

Key People

Founding team and executive leadership

Alex Taylor

Co-Founder & Chief Brand and Creative Officer

Founding Team

Victoria Thain Gioia

Founder Co-CEO

Founding Team

Lauren McMahon

Chief Operating Officer

Executive Team

Perelel Investors

Notable investors and investment history

Perelel investors
InvestorRounds
Selva VenturesSeries A Extension, Series A
Prelude Growth PartnersSeries A Extension
Willow Growth PartnersSeries A Extension, Seed, Series A
Unilever VenturesSeries A Extension, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    The company has achieved profitability within its first five years.

  • Nov 20, 2025

    Raised $27M in a Growth Equity round.

Perelel Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Perelel Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Perelel's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range50
Year Founded2020
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.